Delivery Order SPE2DB22D3501-SPE2DB25FTV35

Award Date 12/16/24
Potential Completion Date 1/8/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTV35
    Delivery Order

This federal contract award, valued at $13,408.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, with a completion date of January 8, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is a child contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. These contract awards demonstrate Amerisourcebergen's extensive capabilities in supplying critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies, to various federal agencies and military healthcare facilities.

Generated 3/17/25, 10:03 AM